USRE39743EExpiredUtilityPatentIndex 50
2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
Est. expiryOct 15, 2018(expired)· nominal 20-yr term from priority
A61P 31/04C07H 17/08
50
PatentIndex Score
1
Cited by
4
References
12
Claims
Abstract
Novel compounds of the formula wherein the substituents are defined as in the application having antibiotic properties.
Claims
exact text as granted — not AI-modified1. A compound selected from the group consisting of the formula
wherein A is nitrogen or N→O, R 1 and R 2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 18 carbon atoms, R is —(CH 2 ) m OB, Hal is halogen, m and n are individually an integer from 1 to 8, B is hydrogen or
or —(CH 2 ) n —Ar, Ar is mono- or polycyclic aryl or heteroaryl, Z is hydrogen or acyl of an organic carboxylic acid of up to 18 carbon atoms and its non-toxic, pharmaceutically acceptable acid addition salts.
2. A compound of claim 1 wherein R 1 and R 2 are hydrogen.
3. A compound of claim 1 wherein A is nitrogen.
4. A compound of claim 1 wherein Hal is fluorine.
5. A compound of claim 1 wherein R is —CH 2 OH.
6. A compound of claim 1 which is (3aS, 4R*, 7S*, 9R*, 10R*, 11R*, 13R*, 15R*, 15aR*, 18S*)-4-ethyl-7-fluoro-3a,4,10,11,12,13,15,15a-octahydro-18-(hydroxymethyl)-11-methoxy-3a,7,9,11,13,15-hexamethyl-10-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-14,1-(nitriloethano)-2H-oxacyclotetradecino[4,3-d]oxazole-2,6,8(7H,9H)-trione.
7. An antibiotic composition comprising an antibiotically effective amount of a compound of claim 1 and an inert pharmaceutical carrier.
8. An antibiotic composition comprising an antibiotically effective amount of a compound of claim 6 and an inert pharmaceutical carrier.
9. A method of treating bacterial infections in warm-blooded animals comprising administering to warm-blooded animals in need thereof an antibiotically effective amount of a compound of claim 1 .
10. A method of treating bacterial infections in warm-blooded animals comprising administering to warm-blooded animals in need thereof an antibiotically effective amount of a compound of claim 6 .
11. A process for the preparation of a compound of claim 1 comprising reacting a compound of the formula
wherein Hal is halogen and OM is a protected hydroxyl with a compound of the formula
wherein m is an integer from 1 to 8 to obtain a compound of the formula
deprotecting the 2′-hydroxyl to obtain a compound of the formula
reacting the latter with a debenzylating agent to obtain a compound of the formula
reacting the latter with a cyclization agent to form a compound of the formula
corresponding to a compound of Formula I of claim 1 wherein R is —(CH 2 ) m —OH and optionally subjecting the latter to an aralkylating or acylating agent to obtain a compound of formula I of claim 1 wherein B is —(CH 2 ) n —Ar or
12. A compound selected from the group consisting of
where the substituents are defined as in claim 11 wherein m, R 1 , R 2 , and Hal are as defined in claim 1 ; and OM is a protected hydroxyl.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.